speb/financial-data huggingface dataset:
BSM balance_sheet (annual, 2025-12-31) — Tangible Book Value: 1128456000.00
BSM balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1128456000.00
BSM income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 9994110.00
BSM income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 4939410.00
BSM income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
BSM income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
BSM balance_sheet (annual, 2025-12-31) — Total Assets: 1335554000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Assets: 1335554000.00
BSM balance_sheet (annual, 2025-12-31) — Total Capitalization: 1282456000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 1282456000.00
BSM balance_sheet (annual, 2025-12-31) — Total Debt: 155985000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Debt: 155985000.00
BSM balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 1128456000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1128456000.00
BSM income_statement (annual, 2025-12-31) — Total Expenses: 161523000.00
BSM income_statement (quarterly, 2025-12-31) — Total Expenses: 43849000.00
BSM balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 207098000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 207098000.00
BSM balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1239918000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1239918000.00
BSM balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 182475000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 182475000.00
BSM income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 308396000.00
BSM income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 74854000.00
BSM balance_sheet (annual, 2025-12-31) — Total Partnership Capital: 1128456000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Partnership Capital: 1128456000.00
BSM balance_sheet (annual, 2025-12-31) — Total Tax Payable: 6029000.00
BSM balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 6029000.00
BSM income_statement (annual, 2025-12-31) — Total Unusual Items: 47591000.00
BSM income_statement (quarterly, 2025-12-31) — Total Unusual Items: 23521000.00
BSM income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 47591000.00
BSM income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 23521000.00
BSM balance_sheet (annual, 2025-12-31) — Working Capital: 71013000.00
BSM balance_sheet (quarterly, 2025-12-31) — Working Capital: 71013000.00
BSM income_statement (quarterly, 2026-03-31) — +Operating Expense: 21846000.00
BSM income_statement (quarterly, 2026-03-31) — +Total Revenue: 123909000.00
BSM balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 2761000.00
BSM balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3754000.00
BSM balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -1881007000.00
BSM income_statement (quarterly, 2026-03-31) — Basic Average Shares: 212369000.00
BSM income_statement (quarterly, 2026-03-31) — Basic EPS: 0.03
BSM cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1478000.00
BSM cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -12110000.00
BSM balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 1053000.00
BSM balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 11612000.00
BSM balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 11612000.00
BSM cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -71066000.00
BSM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -40437000.00
BSM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11989000.00
BSM cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 62560000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -9949000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Payable: -9949000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -9949000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 2821000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Receivables: -9775000.00
BSM cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -16903000.00
BSM cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -9775000.00
BSM cash_flow (quarterly, 2026-03-31) — Changes In Cash: 10134000.00
BSM cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -63700000.00
BSM balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1073682000.00
BSM cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -2335000.00
BSM income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 20878000.00
BSM balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2374000.00
BSM balance_sheet (quarterly, 2026-03-31) — Current Assets: 95691000.00
BSM balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1053000.00
BSM balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1053000.00
BSM balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 40979000.00
BSM cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 9785000.00
BSM balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 8564000.00
BSM income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 212369000.00
BSM income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.03
BSM income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 5906000.00
BSM income_statement (quarterly, 2026-03-31) — EBIT: 16633000.00
BSM income_statement (quarterly, 2026-03-31) — EBITDA: 26418000.00
BSM balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 638000.00
BSM cash_flow (quarterly, 2026-03-31) — End Cash Position: 11612000.00
BSM cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -40437000.00
BSM cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 50450000.00
BSM cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 64550000.00
BSM income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -64550000.00
BSM income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 16832000.00
BSM balance_sheet (quarterly, 2026-03-31) — General Partnership Capital: 0.00
BSM balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3108299000.00
BSM income_statement (quarterly, 2026-03-31) — Gross Profit: 103031000.00
BSM balance_sheet (quarterly, 2026-03-31) — Hedging Assets Current: 1826000.00
BSM income_statement (quarterly, 2026-03-31) — Interest Expense: 3361000.00
BSM income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 3361000.00
BSM income_statement (quarterly, 2026-03-31) — Interest Income: 32000.00
BSM income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 32000.00
BSM cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 3052000.00
BSM balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1260682000.00
BSM cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11989000.00
BSM cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 82000000.00
BSM balance_sheet (quarterly, 2026-03-31) — Limited Partnership Capital: 1073682000.00
BSM balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 187000000.00
BSM balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 187000000.00
BSM cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 82000000.00
BSM cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -49000000.00
BSM balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 22930000.00
BSM cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -2335000.00
BSM balance_sheet (quarterly, 2026-03-31) — Net Debt: 175388000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income: 13272000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 5906000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 13272000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 13272000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 13272000.00
BSM cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 13272000.00
BSM income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 13272000.00
BSM income_statement (quarterly, 2026-03-31) — Net Interest Income: -3329000.00
BSM cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 33000000.00
BSM cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 33000000.00
BSM income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -3329000.00
BSM cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -36000.00
BSM balance_sheet (quarterly, 2026-03-31) — Net PPE: 1227292000.00
BSM cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -11989000.00
BSM balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 0.00
BSM income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 90968000.00
BSM income_statement (quarterly, 2026-03-31) — Normalized Income: 52002000.00
BSM cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 62560000.00
BSM cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 64550000.00
BSM income_statement (quarterly, 2026-03-31) — Operating Income: 81185000.00
BSM income_statement (quarterly, 2026-03-31) — Operating Revenue: 123909000.00
BSM balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 212493000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 6901000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 30293000.00
BSM income_statement (quarterly, 2026-03-31) — Other Gand A: 16832000.00
BSM income_statement (quarterly, 2026-03-31) — Other Income Expense: -64584000.00
BSM cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -11695000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 15433000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4623000.00
BSM income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -34000.00
BSM income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 5014000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Properties: 17044000.00
BSM balance_sheet (quarterly, 2026-03-31) — Other Receivables: 71598000.00
BSM balance_sheet (quarterly, 2026-03-31) — Payables: 4512000.00
BSM balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 6886000.00
BSM balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2747000.00
BSM cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -7366000.00
BSM income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 7366000.00
BSM income_statement (quarterly, 2026-03-31) — Pretax Income: 13272000.00
BSM cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -12110000.00
BSM balance_sheet (quarterly, 2026-03-31) — Receivables: 75352000.00
BSM income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 20878000.00
BSM income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 9785000.00
BSM cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -49000000.00
BSM cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -2335000.00
BSM cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 121000.00
BSM income_statement (quarterly, 2026-03-31) — Selling General And Administration: 16832000.00
BSM balance_sheet (quarterly, 2026-03-31) — Share Issued: 212493000.00
BSM cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3551000.00
BSM balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 0.00
BSM balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1073682000.00
BSM income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -25820000.00
BSM income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
BSM balance_sheet (quarterly, 2026-03-31) — Total Assets: 1338416000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 1260682000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Debt: 188053000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1073682000.00
BSM income_statement (quarterly, 2026-03-31) — Total Expenses: 42724000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 264734000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1242725000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 223755000.00
BSM income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 16635000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Partnership Capital: 1073682000.00
BSM balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1751000.00
BSM income_statement (quarterly, 2026-03-31) — Total Unusual Items: -64550000.00
BSM income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -64550000.00
BSM balance_sheet (quarterly, 2026-03-31) — Working Capital: 54712000.00
BSN.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 100996.00
BSN.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 11795010.00
BSN.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 8889503.00
BSN.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 8889503.00
BSN.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 8889503.00
BSN.AX balance_sheet (annual, 2022-06-30) — Common Stock: 11795010.00
BSN.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Current Assets: 8902317.00
BSN.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 100996.00
BSN.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 1123123.00
BSN.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 3245939.00
BSN.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Net PPE: 3245939.00
BSN.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 81229697.00
BSN.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 1123123.00
BSN.AX balance_sheet (annual, 2022-06-30) — Other Properties: 3245939.00
BSN.AX balance_sheet (annual, 2022-06-30) — Other Receivables: 12814.00
BSN.AX balance_sheet (annual, 2022-06-30) — Payables: 100996.00
BSN.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 100996.00
BSN.AX balance_sheet (annual, 2022-06-30) — Receivables: 12814.00
BSN.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -870873.00
BSN.AX balance_sheet (annual, 2022-06-30) — Share Issued: 81229697.00
BSN.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Assets: 12148256.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 12047260.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 100996.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 3245939.00
BSN.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BSN.AX balance_sheet (annual, 2022-06-30) — Working Capital: 8801321.00
BSN.AX income_statement (annual, 2023-06-30) — +Operating Expense: 1461572.00
BSN.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 29680.00
BSN.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 16885.00
BSN.AX balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -715.00
BSN.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 67138480.00
BSN.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.02
BSN.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 722870.00
BSN.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -2860332.00
BSN.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -2852904.00
BSN.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 12007055.00
BSN.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 5208788.00
BSN.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 5208788.00
BSN.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 5208788.00
BSN.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 8427613.00
BSN.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -2860332.00
BSN.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1081363.00
BSN.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 4485918.00
BSN.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -1232224.00
BSN.AX balance_sheet (annual, 2023-06-30) — Common Stock: 12007055.00
BSN.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 11232268.00
BSN.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 9000000.00
BSN.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -572387.00
BSN.AX balance_sheet (annual, 2023-06-30) — Current Assets: 5236094.00
BSN.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 109382.00
BSN.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 715.00
BSN.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 715.00
BSN.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 715.00
BSN.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 67138480.00
BSN.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.02
BSN.AX income_statement (annual, 2023-06-30) — EBIT: -1461572.00
BSN.AX income_statement (annual, 2023-06-30) — EBITDA: -1460857.00
BSN.AX cash_flow (annual, 2023-06-30) — End Cash Position: 5208788.00
BSN.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 8427613.00
BSN.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -3941695.00
BSN.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 1123123.00
BSN.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 1314372.00
BSN.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 6106271.00
BSN.AX income_statement (annual, 2023-06-30) — Interest Income: 158542.00
BSN.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 158542.00
BSN.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 150861.00
BSN.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 11232268.00
BSN.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -2860332.00
BSN.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 9000000.00
BSN.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 7428.00
BSN.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 8427613.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Net Interest Income: 158542.00
BSN.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 158542.00
BSN.AX balance_sheet (annual, 2023-06-30) — Net PPE: 6105556.00
BSN.AX cash_flow (annual, 2023-06-30) — Net PPE Purchase And Sale: -7428.00
BSN.AX balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 11232268.00
BSN.AX income_statement (annual, 2023-06-30) — Normalized EBITDA: -1460857.00
BSN.AX income_statement (annual, 2023-06-30) — Normalized Income: -1345762.00
BSN.AX income_statement (annual, 2023-06-30) — Operating Income: -1461572.00
BSN.AX balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 81229697.00
BSN.AX balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: 1123123.00
BSN.AX income_statement (annual, 2023-06-30) — Other Gand A: 592840.00
BSN.AX income_statement (annual, 2023-06-30) — Other Income Expense: -42732.00
BSN.AX income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: -42732.00
BSN.AX income_statement (annual, 2023-06-30) — Other Operating Expenses: 146485.00
BSN.AX balance_sheet (annual, 2023-06-30) — Other Payable: 59185.00
BSN.AX balance_sheet (annual, 2023-06-30) — Other Properties: 6098843.00
BSN.AX balance_sheet (annual, 2023-06-30) — Payables: 88865.00
BSN.AX balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 88865.00
BSN.AX cash_flow (annual, 2023-06-30) — Paymentsto Suppliersfor Goodsand Services: -1232224.00
BSN.AX balance_sheet (annual, 2023-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 20517.00
BSN.AX balance_sheet (annual, 2023-06-30) — Prepaid Assets: 10421.00
BSN.AX income_statement (annual, 2023-06-30) — Pretax Income: -1345762.00
BSN.AX cash_flow (annual, 2023-06-30) — Purchase Of PPE: -7428.00
BSN.AX balance_sheet (annual, 2023-06-30) — Receivables: 16885.00
BSN.AX income_statement (annual, 2023-06-30) — Reconciled Depreciation: 715.00
BSN.AX cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -572387.00
BSN.AX balance_sheet (annual, 2023-06-30) — Retained Earnings: -1897910.00
BSN.AX income_statement (annual, 2023-06-30) — Salaries And Wages: 721532.00
BSN.AX income_statement (annual, 2023-06-30) — Selling General And Administration: 1314372.00
BSN.AX balance_sheet (annual, 2023-06-30) — Share Issued: 81229697.00
BSN.AX balance_sheet (annual, 2023-06-30) — Stockholders Equity: 11232268.00
BSN.AX balance_sheet (annual, 2023-06-30) — Tangible Book Value: 11232268.00
BSN.AX income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
BSN.AX income_statement (annual, 2023-06-30) — Tax Provision: 0.00
BSN.AX income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Assets: 11341650.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Capitalization: 11232268.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 11232268.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 109382.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 6105556.00
BSN.AX balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BSN.AX balance_sheet (annual, 2023-06-30) — Working Capital: 5126712.00
BSN.AX income_statement (annual, 2024-06-30) — +Operating Expense: 2889964.00
BSN.AX balance_sheet (annual, 2024-06-30) — Accounts Payable: 24650.00
BSN.AX balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -2510.00
BSN.AX income_statement (annual, 2024-06-30) — Basic Average Shares: 91092809.00
BSN.AX income_statement (annual, 2024-06-30) — Basic EPS: -0.03
BSN.AX cash_flow (annual, 2024-06-30) — Beginning Cash Position: 5208788.00
BSN.AX cash_flow (annual, 2024-06-30) — Capital Expenditure: -4423853.00
BSN.AX cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -4419668.00
BSN.AX balance_sheet (annual, 2024-06-30) — Capital Stock: 15393150.00
BSN.AX balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 2480704.00
BSN.AX balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 2769737.00
BSN.AX balance_sheet (annual, 2024-06-30) — Cash Financial: 2480704.00
BSN.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: 3116095.00
BSN.AX cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -4712886.00
BSN.AX cash_flow (annual, 2024-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1136753.00
BSN.AX cash_flow (annual, 2024-06-30) — Changes In Cash: -2733544.00
BSN.AX cash_flow (annual, 2024-06-30) — Classesof Cash Payments: -1281953.00
BSN.AX balance_sheet (annual, 2024-06-30) — Common Stock: 15393150.00
BSN.AX balance_sheet (annual, 2024-06-30) — Common Stock Equity: 11839129.00
BSN.AX cash_flow (annual, 2024-06-30) — Common Stock Issuance: 3339188.00
BSN.AX cash_flow (annual, 2024-06-30) — Common Stock Payments: -223093.00
BSN.AX balance_sheet (annual, 2024-06-30) — Current Assets: 2800199.00
BSN.AX balance_sheet (annual, 2024-06-30) — Current Liabilities: 132847.00
BSN.AX income_statement (annual, 2024-06-30) — Depreciation Amortization Depletion Income Statement: 1795.00
BSN.AX income_statement (annual, 2024-06-30) — Depreciation And Amortization In Income Statement: 1795.00
BSN.AX income_statement (annual, 2024-06-30) — Depreciation Income Statement: 1795.00
BSN.AX income_statement (annual, 2024-06-30) — Diluted Average Shares: 91092809.00
BSN.AX income_statement (annual, 2024-06-30) — Diluted EPS: -0.03
BSN.AX income_statement (annual, 2024-06-30) — EBIT: -2889964.00
BSN.AX income_statement (annual, 2024-06-30) — EBITDA: -2888169.00
BSN.AX cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: 5460.00
BSN.AX cash_flow (annual, 2024-06-30) — End Cash Position: 2480704.00
BSN.AX cash_flow (annual, 2024-06-30) — Financing Cash Flow: 3116095.00
BSN.AX cash_flow (annual, 2024-06-30) — Free Cash Flow: -5560606.00
BSN.AX balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: 1099734.00
BSN.AX income_statement (annual, 2024-06-30) — General And Administrative Expense: 817329.00
BSN.AX balance_sheet (annual, 2024-06-30) — Gross PPE: 9174287.00
BSN.AX income_statement (annual, 2024-06-30) — Interest Income: 145465.00
BSN.AX income_statement (annual, 2024-06-30) — Interest Income Non Operating: 145465.00
BSN.AX cash_flow (annual, 2024-06-30) — Interest Received Direct: 145200.00
BSN.AX balance_sheet (annual, 2024-06-30) — Invested Capital: 11839129.00
BSN.AX cash_flow (annual, 2024-06-30) — Investing Cash Flow: -4712886.00
BSN.AX cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 3339188.00
BSN.AX balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 11613.00
BSN.AX cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 3116095.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Net Interest Income: 145465.00
BSN.AX cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: -289033.00
BSN.AX income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 145465.00
BSN.AX balance_sheet (annual, 2024-06-30) — Net PPE: 9171777.00
BSN.AX cash_flow (annual, 2024-06-30) — Net PPE Purchase And Sale: -4185.00
BSN.AX balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 11839129.00
BSN.AX income_statement (annual, 2024-06-30) — Normalized EBITDA: -2888169.00
BSN.AX income_statement (annual, 2024-06-30) — Normalized Income: -2755845.00
BSN.AX income_statement (annual, 2024-06-30) — Operating Income: -2889964.00
BSN.AX balance_sheet (annual, 2024-06-30) — Ordinary Shares Number: 104349620.00
BSN.AX balance_sheet (annual, 2024-06-30) — Other Equity Adjustments: 1099734.00
BSN.AX income_statement (annual, 2024-06-30) — Other Gand A: 183417.00
BSN.AX income_statement (annual, 2024-06-30) — Other Income Expense: -11346.00
BSN.AX income_statement (annual, 2024-06-30) — Other Non Operating Income Expenses: -11346.00
BSN.AX income_statement (annual, 2024-06-30) — Other Operating Expenses: 1844166.00
BSN.AX balance_sheet (annual, 2024-06-30) — Other Payable: 66574.00
BSN.AX balance_sheet (annual, 2024-06-30) — Other Properties: 9162674.00
BSN.AX balance_sheet (annual, 2024-06-30) — Other Receivables: 18845.00
BSN.AX balance_sheet (annual, 2024-06-30) — Other Short Term Investments: 289033.00
BSN.AX balance_sheet (annual, 2024-06-30) — Payables: 91224.00
BSN.AX balance_sheet (annual, 2024-06-30) — Payables And Accrued Expenses: 91224.00
BSN.AX cash_flow (annual, 2024-06-30) — Paymentsto Suppliersfor Goodsand Services: -1281953.00
BSN.AX balance_sheet (annual, 2024-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 41623.00
BSN.AX balance_sheet (annual, 2024-06-30) — Prepaid Assets: 11617.00
BSN.AX income_statement (annual, 2024-06-30) — Pretax Income: -2755845.00
BSN.AX cash_flow (annual, 2024-06-30) — Purchase Of Investment: -289033.00
BSN.AX cash_flow (annual, 2024-06-30) — Purchase Of PPE: -4185.00
BSN.AX balance_sheet (annual, 2024-06-30) — Receivables: 18845.00
BSN.AX income_statement (annual, 2024-06-30) — Reconciled Depreciation: 1795.00
BSN.AX cash_flow (annual, 2024-06-30) — Repurchase Of Capital Stock: -223093.00
BSN.AX balance_sheet (annual, 2024-06-30) — Retained Earnings: -4653755.00
BSN.AX income_statement (annual, 2024-06-30) — Salaries And Wages: 633912.00
BSN.AX income_statement (annual, 2024-06-30) — Selling And Marketing Expense: 226674.00
BSN.AX income_statement (annual, 2024-06-30) — Selling General And Administration: 1044003.00
BSN.AX balance_sheet (annual, 2024-06-30) — Share Issued: 104349620.00
BSN.AX balance_sheet (annual, 2024-06-30) — Stockholders Equity: 11839129.00
BSN.AX balance_sheet (annual, 2024-06-30) — Tangible Book Value: 11839129.00
BSN.AX income_statement (annual, 2024-06-30) — Tax Effect Of Unusual Items: 0.00
BSN.AX income_statement (annual, 2024-06-30) — Tax Provision: 0.00
BSN.AX income_statement (annual, 2024-06-30) — Tax Rate For Calcs: 0.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Assets: 11971976.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Capitalization: 11839129.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Equity Gross Minority Interest: 11839129.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Liabilities Net Minority Interest: 132847.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Non Current Assets: 9171777.00
BSN.AX balance_sheet (annual, 2024-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BSN.AX balance_sheet (annual, 2024-06-30) — Working Capital: 2667352.00
BSN.DE balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 982000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 215000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Current Debt: 3552000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 2956000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 771000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Long Term Provisions: 1823000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 8765000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Net Debt: 14568000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Other Inventories: 127000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Other Payable: 1599000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Other Properties: 2443000000.00
BSN.DE income_statement (annual, 2021-12-31) — Total Unusual Items Excluding Goodwill: -1074000000.00
BSN.DE balance_sheet (annual, 2021-12-31) — Work In Process: 209000000.00
BSN.DE income_statement (annual, 2022-12-31) — +Operating Expense: 9488000000.00
BSN.DE income_statement (annual, 2022-12-31) — +Total Revenue: 27661000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Accounts Payable: 4899000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Accounts Receivable: 3272000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -9889000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 5188000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -98000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 202000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 468000000.00
BSN.DE income_statement (annual, 2022-12-31) — Basic Average Shares: 639050821.00
BSN.DE income_statement (annual, 2022-12-31) — Basic EPS: 1.48
BSN.DE cash_flow (annual, 2022-12-31) — Beginning Cash Position: 659000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Capital Expenditure: -873000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -873000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 933000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Capital Stock: 169000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 1051000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 4682000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -1238000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Cash Financial: 1051000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Change In Inventory: -667000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 289000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Change In Payable: 879000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Change In Receivables: -424000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Change In Working Capital: 77000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Changes In Cash: 281000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Common Stock: 169000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Common Stock Equity: 17923000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Common Stock Issuance: 51000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
BSN.DE income_statement (annual, 2022-12-31) — Cost Of Revenue: 14922000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Current Assets: 12153000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 203000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Current Debt: 3155000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 3358000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Current Liabilities: 12130000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Deferred Tax: 40000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Depreciation: 1863000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1863000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 432000000.00
BSN.DE income_statement (annual, 2022-12-31) — Diluted Average Shares: 639484607.00
BSN.DE income_statement (annual, 2022-12-31) — Diluted EPS: 1.48
BSN.DE income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 945000000.00
BSN.DE income_statement (annual, 2022-12-31) — EBIT: 2140000000.00
BSN.DE income_statement (annual, 2022-12-31) — EBITDA: 4003000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 112000000.00
BSN.DE cash_flow (annual, 2022-12-31) — End Cash Position: 1051000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Financial Assets: 18000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Financing Cash Flow: -1934000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Finished Goods: 1366000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Free Cash Flow: 2091000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: 78000000.00
BSN.DE income_statement (annual, 2022-12-31) — General And Administrative Expense: 2637000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Goodwill: 17938000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 24240000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 3370000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Gross PPE: 16641000000.00
BSN.DE income_statement (annual, 2022-12-31) — Gross Profit: 12739000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 144000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 4000000.00
BSN.DE income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 658000000.00
BSN.DE income_statement (annual, 2022-12-31) — Interest Expense: 308000000.00
BSN.DE income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 308000000.00
BSN.DE income_statement (annual, 2022-12-31) — Interest Income: 155000000.00
BSN.DE income_statement (annual, 2022-12-31) — Interest Income Non Operating: 155000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Interest Paid Cff: -18000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Inventories Adjustments Allowances: -233000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Inventory: 2619000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Invested Capital: 31154000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Investing Cash Flow: -749000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 468000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Investments In Other Ventures Under Equity Method: 917000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 576000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 51000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Issuance Of Debt: 600000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 730000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Long Term Debt: 10076000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 10806000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 600000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -1682000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 917000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1074000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 8965000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Minority Interest: 69000000.00
BSN.DE income_statement (annual, 2022-12-31) — Minority Interests: -64000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 106000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 51000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Net Debt: 12180000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income: 959000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 945000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1022000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 959000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 959000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1023000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1023000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Interest Income: -310000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: -2114000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -1082000000.00
BSN.DE income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -310000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 1465000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Net PPE: 6752000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: 30000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -1032000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -6317000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 735000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 1583000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 772000000.00
BSN.DE income_statement (annual, 2022-12-31) — Normalized EBITDA: 5078000000.00
BSN.DE income_statement (annual, 2022-12-31) — Normalized Income: 1765250000.00
BSN.DE cash_flow (annual, 2022-12-31) — Operating Cash Flow: 2964000000.00
BSN.DE income_statement (annual, 2022-12-31) — Operating Income: 3251000000.00
BSN.DE income_statement (annual, 2022-12-31) — Operating Revenue: 27661000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 639607931.00
BSN.DE cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: -1000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Current Assets: 1231000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Current Liabilities: -62000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Equity Interest: -1000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 6302000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Inventories: 198000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Other Non Cash Items: 46000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Non Current Assets: -2000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 492000000.00
BSN.DE income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -33000000.00
BSN.DE income_statement (annual, 2022-12-31) — Other Operating Expenses: 218000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Payable: 1923000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Properties: 2438000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Receivables: 3000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 3631000000.00
BSN.DE income_statement (annual, 2022-12-31) — Other Special Charges: -2000000.00
BSN.DE income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 14000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Payables: 6822000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 1113000000.00
BSN.DE income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 0.00
BSN.DE income_statement (annual, 2022-12-31) — Pretax Income: 1832000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Properties: 5238000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -241000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Purchase Of Business: -100000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Raw Materials: 1044000000.00
BSN.DE income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 14922000000.00
BSN.DE income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1863000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Repayment Of Debt: -1682000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
BSN.DE income_statement (annual, 2022-12-31) — Research And Development: 339000000.00
BSN.DE income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 419000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Retained Earnings: 17916000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Sale Of Business: 206000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Sale Of PPE: 30000000.00
BSN.DE income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 6294000000.00
BSN.DE income_statement (annual, 2022-12-31) — Selling General And Administration: 8931000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Share Issued: 675837932.00
BSN.DE income_statement (annual, 2022-12-31) — Special Income Charges: -1075000000.00
BSN.DE cash_flow (annual, 2022-12-31) — Stock Based Compensation: 25000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Stockholders Equity: 17923000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Tangible Book Value: -6317000000.00
BSN.DE income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -268750000.00
BSN.DE income_statement (annual, 2022-12-31) — Tax Provision: 778000000.00
BSN.DE income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
BSN.DE balance_sheet (annual, 2022-12-31) — Total Assets: 45281000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Capitalization: 27999000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Debt: 14164000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 17992000000.00
BSN.DE income_statement (annual, 2022-12-31) — Total Expenses: 24410000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 27289000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 33128000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 15159000000.00
BSN.DE income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 2143000000.00
BSN.DE income_statement (annual, 2022-12-31) — Total Other Finance Cost: 157000000.00
BSN.DE income_statement (annual, 2022-12-31) — Total Unusual Items: -1075000000.00
BSN.DE income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -1075000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 36230001.00
BSN.DE balance_sheet (annual, 2022-12-31) — Treasury Stock: 1569000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Work In Process: 244000000.00
BSN.DE balance_sheet (annual, 2022-12-31) — Working Capital: 23000000.00
BSN.DE income_statement (annual, 2023-12-31) — +Operating Expense: 9595000000.00
BSN.DE income_statement (annual, 2023-12-31) — +Total Revenue: 27619000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Accounts Payable: 4779000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Accounts Receivable: 2919000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -9618000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 5256000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -123000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 376000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 392000000.00
BSN.DE income_statement (annual, 2023-12-31) — Basic Average Shares: 641030818.00
BSN.DE income_statement (annual, 2023-12-31) — Basic EPS: 1.36
BSN.DE cash_flow (annual, 2023-12-31) — Beginning Cash Position: 1051000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Capital Expenditure: -847000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -847000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 879000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Capital Stock: 169000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 2363000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 6001000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -1279000000.00
BSN.DE balance_sheet (annual, 2023-12-31) — Cash Financial: 2363000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Change In Inventory: 41000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -162000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Change In Payable: 324000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Change In Receivables: 74000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Change In Working Capital: 277000000.00
BSN.DE cash_flow (annual, 2023-12-31) — Changes In Cash: 551000000.00